Role of polymorphisms of γ-glutamylcysteine synthetase genes in pathogenesis of coronary spastic angina
γ-谷氨酰半胱氨酸合成酶基因多态性在冠状动脉痉挛性心绞痛发病机制中的作用
基本信息
- 批准号:13670728
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Human glutamate-cysteine ligase (GCL) is a rate-limiting enzyme for synthesis of glutathione (GSH) that plays a crucial role in antioxidant defense mechanisms in most mammalian cells, including vascular cells. GCL is a heterodimer composed of a heavy catalytic subunit (GCLC) and a light modifier subunit (GCLM). Oxidants transcriptionally upregulate GCL genes for GSH synthesis, providing a protective mechanism against oxidative stress-induced cellular dysfunction. We found a polymorphism (-588C/T) of GCLM gene and a polymorphism (-129C/T) of GCLC gene in which minor alleles showed lower promoter activity in response to oxidants in the luciferase reporter gene assay. The induction of GCLM mRNA expression in the cultured human monocytes-macrophages was less in the cells from subjects with the minor allele as compared with those without minor allele. Plasma GSH levels were significantly lower in subjects with the minor allele of GCLM polymorphism than those without the minor allele (2.1±0.3 versus 3.3±0.2 μmol/L; P=0.001). The frequency of each of the minor alleles was significantly higher in those with previous myocardial infarction than in the control. In multiple logistic regression analysis, each of the minor alleles of GCLC and GCLM genes was a risk factor for myocardial infarction independently of traditional coronary risk factors. Endothelium-dependent dilation of coronary arteries was impaired in the subjects with the minor allele of GCLC gene polymorphism as compared with the age-matched those without the minor allele. In conclusion the polymorphisms of GCLC and GCLM genes may suppress GCL genes induction response to an oxidant and it is implicated in coronary endothelial vasomotor dysfunction and myocardial infarction.
人谷氨酸-半胱氨酸连接酶(GCL)是谷胱甘肽(GSH)合成的限速酶,在大多数哺乳动物细胞(包括血管细胞)的抗氧化防御机制中起着至关重要的作用。GCL是由重催化亚基(GCLC)和轻修饰亚基(GCLM)组成的异二聚体。氧化剂转录上调GSH合成的GCL基因,为氧化应激诱导的细胞功能障碍提供保护机制。在荧光素酶报告基因检测中,我们发现GCLM基因的一个多态性(-588C/T)和GCLC基因的一个多态性(-129C/T),其中小的等位基因对氧化剂的反应表现出较低的启动子活性。在培养的人单核-巨噬细胞中,GCLM mRNA表达的诱导作用在来自具有次要等位基因的受试者的细胞中比在不具有次要等位基因的受试者的细胞中更小。携带GCLM基因次要等位基因的受试者血浆GSH水平显著低于不携带该等位基因的受试者(2.1±0.3 vs 3.3±0.2 μmol/L; P=0.001)。有心肌梗死史的患者中每个次要等位基因的频率均显著高于对照组。多元Logistic回归分析显示,GCLC和GCLM基因的每个次要等位基因都是心肌梗死的危险因素,独立于传统的冠状动脉危险因素。与年龄匹配的无GCLC基因多态性的受试者相比,GCLC基因多态性的次要等位基因的受试者的冠状动脉内皮依赖性扩张受损。结论GCLC和GCLM基因多态性可能抑制GCL基因对氧化剂的诱导反应,并与冠状动脉内皮功能障碍和心肌梗死有关。
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sakamoto T, Kugiyama K, et al.: "B-type natriuretic peptide after percutaneous transluminal septal myocardial ablation"Int J Cardiol. 83. 151-158 (2002)
Sakamoto T、Kugiyama K 等人:“经皮腔内间隔心肌消融术后的 B 型利钠肽”Int J Cardiol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kawano H, Kugiyama K, et al.: "Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina"Ann Intern Med. 135. 977-981 (2001)
Kawano H、Kugiyama K 等人:“患有变异性心绞痛的绝经前妇女心肌缺血的月经周期变化”Ann Intern Med。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kawano H, Kugiyama K, et al.: "Endothelial function fluctuates with diurnal variation in the frequency of ischemic episodes in patients with variant angina"J Am Coil Cardiol. 40. 266-270 (2002)
Kawano H、Kugiyama K 等人:“变异性心绞痛患者缺血发作频率的昼夜变化会导致内皮功能波动”J Am Coil Cardiol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nakamura S, Kugiyama K, et al.: "Polymorphism in the 5'-flanking region of human glutamate-cysteine ligasemodifier subunit gene is associated with myocardial infarction"Circulation. 105. 2968-2973 (2002)
Nakamura S、Kugiyama K 等人:“人谷氨酸-半胱氨酸连接酶修饰剂亚基基因 5-侧翼区域的多态性与心肌梗塞相关”循环。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Koide S, Kugiyama K, et al.: "Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction"J Am Coil Cardiol. 41. 539-545 (2003)
Koide S、Kugiyama K 等人:“谷氨酸-半胱氨酸连接酶催化亚基基因多态性与冠状动脉血管舒缩功能障碍和心肌梗塞的关联”J Am Coil Cardiol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KUGIYAMA Kiyotaka其他文献
KUGIYAMA Kiyotaka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KUGIYAMA Kiyotaka', 18)}}的其他基金
A study of role of phospholipase A2 receptor in pathogenosis ofcardiovascular diseases and development of new drug for cardiovascular diseases
磷脂酶A2受体在心血管疾病发病机制中的作用研究及心血管疾病新药开发
- 批准号:
22390158 - 财政年份:2010
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A study of role of phospholipase A2 in pathogenosis of cardiovascular diseases and development of new drug for cardiovascular diseases
磷脂酶A2在心血管疾病发病中的作用研究及心血管疾病新药开发
- 批准号:
19390209 - 财政年份:2007
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Clinical significance of remnant lipoproteinemia as a therapeutic target of cardiovascular diseases
残余脂蛋白血症作为心血管疾病治疗靶点的临床意义
- 批准号:
15390244 - 财政年份:2003
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Role of oxidative stress in pathogenesis of coronary spasm, a molecular biological and clinical study
氧化应激在冠状动脉痉挛发病机制中的作用,分子生物学和临床研究
- 批准号:
11670693 - 财政年份:1999
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effects of remnant lipoproteins on functions of endothelial cells, smooth muscle
残余脂蛋白对内皮细胞、平滑肌功能的影响
- 批准号:
09670730 - 财政年份:1997
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effects of lysolecithin on the regulation of gene transcription in endothelial cells and plasma levels of secretary type II phospholipase A2 in coronary artery disease
溶血卵磷脂对冠心病内皮细胞基因转录及血浆分泌型II型磷脂酶A2水平的影响
- 批准号:
07670793 - 财政年份:1995
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effects of natriuretic peptides on the mechanisms of atherosclerosis
利钠肽对动脉粥样硬化机制的影响
- 批准号:
05670622 - 财政年份:1993
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Effects of oxidized low density lipoprotein on vascular endothelial and smooth muscle cells
氧化低密度脂蛋白对血管内皮和平滑肌细胞的影响
- 批准号:
03670460 - 财政年份:1991
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Relationship between coronary spastic angina and glycemic fluctuation
冠状动脉痉挛性心绞痛与血糖波动的关系
- 批准号:
19K09398 - 财政年份:2019
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of calcium/calmodulin-dependent protein kinase II and development of new treatment strategy for coronary spastic angina
钙/钙调蛋白依赖性蛋白激酶II的作用及冠状动脉痉挛性心绞痛新治疗策略的开发
- 批准号:
19K08530 - 财政年份:2019
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A new mechanism of coronary spastic angina: Possible role of beta-arrestin
冠状动脉痉挛性心绞痛的新机制:β-抑制素的可能作用
- 批准号:
18K15875 - 财政年份:2018
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of novel mechanism and development of treatment strategy for coronary spastic angina through regulation of calcium sensitization
通过调节钙敏化阐明冠状动脉痉挛性心绞痛的新机制并开发治疗策略
- 批准号:
16K09489 - 财政年份:2016
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular biological approach to the pathogenesis of coronary spastic angina: A study on the role of p122 protein
冠状动脉痉挛性心绞痛发病机制的分子生物学方法:p122 蛋白作用的研究
- 批准号:
26461120 - 财政年份:2014
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Experimental study on calcium signaling in coronary spastic angina animal model
冠状动脉痉挛性心绞痛动物模型中钙信号传导的实验研究
- 批准号:
25860577 - 财政年份:2013
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Molecular biological approach to the pathogenesis of coronary spastic angina: A study on the role of p122 protein
冠状动脉痉挛性心绞痛发病机制的分子生物学方法:p122 蛋白作用的研究
- 批准号:
23591077 - 财政年份:2011
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular and Biological Approaches to the Genesis of Coronary Spastic Angina : With special reference to the intracellular signaling pathway participating coronary artery contraction
冠状动脉痉挛性心绞痛发生的分子和生物学方法:特别参考参与冠状动脉收缩的细胞内信号通路
- 批准号:
15590712 - 财政年份:2003
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular Mechanism for Coronary Spastic Angina as a Transcriptional Factor-Related Disease
冠状动脉痉挛性心绞痛作为转录因子相关疾病的分子机制
- 批准号:
11557053 - 财政年份:1999
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Genetic analysis of endothelial nitric oxide synthase in patients with coronary spastic angina
冠状动脉痉挛性心绞痛患者内皮型一氧化氮合酶基因分析
- 批准号:
09670732 - 财政年份:1997
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)